Anonymous
Guest
Anonymous
Guest
Two little turd companies combine to make one big shit company!
Who cares anyway?
Who cares anyway?
Two little turd companies combine to make one big shit company!
Who cares anyway?
Salix is too reliant on xiafaxan. Going forward I see strong headwinds from hcv oral therapys plus i do not see pcp's and Im's writing it for Ibs D (not gonna happen).
The other products are junk and the reps are cheeser cheesers
VOTE NO
Word out of Chesterbrook is that Salix is asking for north of $170 per share. Shire will not pursue.
Of course they are looking at North of 170. That's a no brainer...
Both Valeant and Shire leaking articles on the same day. This is going to get interesting!